Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04661046

Enrollment

100

Registered

2020-12-09

Start date

2020-11-30

Completion date

2022-08-31

Last updated

2020-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gene Mutation-Related Cancer, Traditional Chinese Medicine

Brief summary

To explore the correlation between gene mutations of metastatic colorectal cancer and TCM syndrome types based on Second-generation sequencing technology.

Interventions

DRUGTraditional Chinese Medicine

Chinese medicine prescription

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. A clear pathological diagnosis is a patient with colorectal cancer; 2. Have complete TNM staging information; 3. There is a clear diagnosis of the location and time of metastasis; 4. Age ≥18 years old, ≤80 years old, male or female; 5. There is a clear time for the first treatment with Chinese medicine; 6. Patients who can receive long-term follow-up. -

Exclusion criteria

1. Patients with colorectal cancer diagnosed pathologically as adenosquamous carcinoma, squamous cell carcinoma, carcinoid, small cell carcinoma, malignant lymphoma, etc.; 2. Patients with double cancer, multiple or metastatic colorectal cancer; 3. Combined with severe acute and chronic diseases that may affect treatment and prognosis, such as myocardial infarction, stroke, severe renal insufficiency and mental illness;-

Design outcomes

Primary

Measure	Time frame	Description
Overall Survival	2 years	OS
Progression Free Survival	2 years	PFS

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026